1. SCIDOT-14. ENHANCING BRAIN RETENTION OF A KIF11 INHIBITOR SIGNIFICANTLY IMPROVES ITS EFFICACY IN A MOUSE MODEL OF GLIOBLASTOMA. (11th November 2019) Authors: Gampa, Gautham; Kenchappa, Rajappa; Mohammad, Afroz; Parrish, Karen; Kim, Minjee; Sarkaria, Jann; Rosenfeld, Steven; Elmquist, William Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS. (11th November 2019) Authors: Jackson, Pamela; Kim, Minjee; Hawkins-Daarud, Andrea; Singleton, Kyle; Mohammad, Afroz; Burns, Terence; Parney, Ian; Hu, Leland; Kaufmann, Timothy; Elmquist, William; Sarkaria, Jann; Swanson, Kristin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BIOM-44. PRE-SURGICAL ADVANCED MRI IS USEFUL FOR FORECASTING DRUG DISTRIBUTION IN BRAIN TUMORS. (12th November 2021) Authors: Jackson, Pamela; Kim, Minjee; Hawkins-Daarud, Andrea; Singleton, Kyle; Mohammad, Afroz; Burns, Terence; Parney, Ian; Hu, Leland; Kaufmann, Timothy; Elmquist, William; Sarkaria, Jann; Swanson, Kristin Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DDDR-28. EGFR AND SRC-MEDIATED ACTIVATION OF STAT3 DRIVES RESISTANCE TO MITOTIC INHIBITORS IN GLIOBLASTOMA, AND CAN BE REVERSED WITH FDA-APPROVED DRUGS. (14th November 2022) Authors: Kenchappa, Rajappa; Dovas, Athanassios; Argenziano, Michael; Meyer, Christian; Stopfer, Lauren; Banu, Matei; Pereira, Brianna; Griffith, Jessica; Mohammad, Afroz; Talele, Surabhi; Zarco, Natanael; Elmquist, William F; White, Forest; Quaranta, Vito; Sims, Peter; Canoll, Peter; Rosenfeld, Steven Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EMBR-28. CNS DISTRIBUTIONAL KINETICS OF PANOBINOSTAT IN THE MOUSE. (1st June 2021) Authors: Zhang, Wenqiu; Mohammad, Afroz; Sirianni, Rachael; Elmquist, William Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High-Dose MTX110 (Soluble Panobinostat) Safely Administered into the Fourth Ventricle in a Nonhuman Primate Model. (16th November 2020) Authors: Kharas, Natasha; Yu, Bangning; Janssen, Christopher; Trimble, Amanda; Ballester, Leomar; Patel, Rajan; Mohammad, Afroz; Elmquist, William; Sirianni, Rachael W; Sandberg, David I Journal: Neurosurgery Issue: Volume 67(2010)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer. Issue 1 (December 2015) Authors: Adkins, Chris; Nounou, Mohamed; Hye, Tanvirul; Mohammad, Afroz; Terrell-Hall, Tori; Mohan, Neel; Eldon, Michael; Hoch, Ute; Lockman, Paul Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗